HORAN Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$758K Buy
824
+15
+2% +$15.2K 0.07% 117
2025
Q4
$869K Buy
809
+9
+1% +$8.61K 0.13% 88
2025
Q3
$610K Hold
800
0.1% 121
2025
Q2
$624K Buy
+800
New +$622K 0.19% 70

Other funds holding LLY

HORAN Wealth's LLY Position: Q1 2026 in Review

HORAN Wealth increased its Eli Lilly (LLY) stake by 1.9% in Q1 2026, buying an estimated $15.2K and bringing the position to 824 shares worth $758K. The position accounts for 0.07% of the portfolio, ranked #117.

HORAN Wealth first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $869K in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • HORAN Wealth held 824 shares of Eli Lilly worth $758K as of Q1 2026.
  • HORAN Wealth bought 15 Eli Lilly shares in Q1 2026, an estimated $15.2K.
  • Eli Lilly made up 0.07% of HORAN Wealth's portfolio in Q1 2026, its #117 holding.
  • HORAN Wealth first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
  • HORAN Wealth's Eli Lilly position peaked at $869K in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on HORAN Wealth's 13F filing for Q1 2026, filed 8 May 2026.